KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) FCF Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2,638.00
Dec 31, 2025 -1,493.00
Sep 30, 2025 2,896.00
Jun 30, 2025 -1,408.00
Mar 31, 2025 -1,967.00
Dec 31, 2024 861.00
Sep 30, 2024 490.00
Jun 30, 2024 -1,324.00
Mar 31, 2024 146.00
Dec 31, 2023 -2,049.00
Sep 30, 2023 2,167.00
Jun 30, 2023 -56.00
Mar 31, 2023 572.00
Dec 31, 2022 1,011.00
Sep 30, 2022 305.00
Jun 30, 2022 -924.00
Mar 31, 2022 1,899.00
Dec 31, 2021 1,073.00
Sep 30, 2021 2,138.00
Jun 30, 2021 2,070.00
Mar 31, 2021 4,368.00
Dec 31, 2020 1,378.00
Sep 30, 2020 1,293.00
Jun 30, 2020 4,532.00
Mar 31, 2020 2,267.00
Dec 31, 2019 1,534.00
Sep 30, 2019 1,909.00
Jun 30, 2019 584.00
Mar 31, 2019 694.00
Dec 31, 2018 2,742.00
Sep 30, 2018 -432.00
Jun 30, 2018 -1,982.00
Mar 31, 2018 3,220.00
Dec 31, 2017 7.00
Sep 30, 2017 -9,141.00
Jun 30, 2017 299.00
Mar 31, 2017 654.00
Dec 31, 2016 -585.00
Sep 30, 2016 -860.00
Jun 30, 2016 -1,510.00
Mar 31, 2016 -1,881.00
Dec 31, 2015 -1,479.00
Sep 30, 2015 -1,984.00
Jun 30, 2015 -2,256.00
Mar 31, 2015 516.00
Dec 31, 2014 -1,386.00
Sep 30, 2014 -693.00